For research use only. Not for therapeutic Use.
Nemonoxacin（Cat No.:M008278）is a broad-spectrum, non-fluorinated quinolone antibiotic developed for the treatment of bacterial infections. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication and cell division. Nemonoxacin has demonstrated activity against a wide range of gram-positive and gram-negative bacteria, including drug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA). It is being investigated for its potential in treating respiratory, urinary tract, and skin infections, offering an alternative to traditional fluoroquinolones, particularly in cases where resistance to common antibiotics is a concern.
| CAS Number | 378746-64-6 |
| Synonyms | 7-[(3S,5S)-3-amino-5-methylpiperidin-1-yl]-1-cyclopropyl-8-methoxy-4-oxoquinoline-3-carboxylic acid |
| Molecular Formula | C20H25N3O4 |
| Purity | ≥95% |
| IUPAC Name | 7-[(3S,5S)-3-amino-5-methylpiperidin-1-yl]-1-cyclopropyl-8-methoxy-4-oxoquinoline-3-carboxylic acid |
| InChI | InChI=1S/C20H25N3O4/c1-11-7-12(21)9-22(8-11)16-6-5-14-17(19(16)27-2)23(13-3-4-13)10-15(18(14)24)20(25)26/h5-6,10-13H,3-4,7-9,21H2,1-2H3,(H,25,26)/t11-,12-/m0/s1 |
| InChIKey | AVPQPGFLVZTJOR-RYUDHWBXSA-N |
| SMILES | C[C@H]1C[C@@H](CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N |
